Home > Financial Ratios > WOCKHARDT

WOCKHARDT
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for WOCKHARDT
Please provide your vote to see the results

WOCKHARDT Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 272.95-45.29-29.87360.87-56.28

What is the latest Core EBITDA Growth ratio of WOCKHARDT ?

The latest Core EBITDA Growth ratio of WOCKHARDT is 272.95 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025272.95
Mar2024-45.29
Mar2023-29.87
Mar2022360.87
Mar2021-56.28

How is Core EBITDA Growth of WOCKHARDT Trending?

Years Core EBITDA Growth % Change
Mar2025 272.95
Positive
Mar2024 -45.29
Negative
Mar2023 -29.87
Negative
Mar2022 360.87
Positive
Mar2021 -56.28 -

Other Financial Ratios of WOCKHARDT


Compare Core EBITDA Growth ratio of peers of WOCKHARDT

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WOCKHARDT ₹23,902.1 Cr -3% -14.9% 52.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹384,002.0 Cr 1.9% -2.1% -6.2% Stock Analytics
DIVIS LABORATORIES ₹164,334.0 Cr 2.7% -5.6% 25.2% Stock Analytics
CIPLA ₹127,613.0 Cr 3.4% 7.7% 0.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,923.0 Cr 0.6% 4.4% 9.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,437.0 Cr 3.2% 1.6% -8.4% Stock Analytics


WOCKHARDT Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WOCKHARDT

-3%

-14.9%

52.6%

SENSEX

-1.1%

-1.7%

-0.3%


You may also like the below Video Courses